JPMorgan Healthcare Leaders ETF

Frequently Asked Questions About JDOC

What does JDOC invest in?

The fund primarily allocates its capital to the common stock of companies within the broad healthcare sector, specifically targeting businesses engaged in pharmaceuticals, biotechnology, healthcare services, health technology, medical technology, and life sciences. The adviser seeks out industry leaders in these areas whose potential for future growth, both in scale and longevity, is believed to be underestimated by the market. Under typical market conditions, a minimum of 80% of the fund's assets will be invested in the equity securities of such healthcare-related enterprises.

What is the expense ratio of JDOC?

JPMorgan Healthcare Leaders ETF (JDOC) charges an expense ratio of 0.65%. This is the annual fee deducted from fund assets to cover management and operations.

How big is JDOC?

JPMorgan Healthcare Leaders ETF (JDOC) manages $9.6M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is JDOC actively managed or an index fund?

JDOC's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was JDOC launched?

JPMorgan Healthcare Leaders ETF (JDOC) launched in November 2023 and is managed by J.P. Morgan.

How has JDOC performed?

JDOC's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.